| BCBS Florida Coverage Guidelines | Infliximab Products [infliximab (Remicade®), (09-J0000-39) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Intensity-Modulated Radiation Therapy (04-77260-22) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Investigational Services (09-A0000-03) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Irreversible Electroporation (IRE) (02-40000-26) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Ixekizumab (Taltz®) Injection (09-J2000-62) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Lecanemab-irmb (Leqembi, Leqembi Iqlik) (09-J4000-41) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Linvoseltamab-gcpt (Lynozyfic) IV Infusion (09-J5000-27) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Minimally Invasive Fusion Techniques (02-61000-36) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Mirikizumab-mrkz (Omvoh®) Injection and (09-J4000-71) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Nemolizumab-ilto (Nemluvio) Injection (09-J4000-99) | 2026-01-01 |